Concomitant primary hematochromatosis and β-thalassemia trait: Iron depletion by erythrocytapheresis and desferrioxamine

M. Cesana, C. Mandelli, C. Tiribelli, P. A. Bianchi, D. Conte

Research output: Contribution to journalArticlepeer-review

Abstract

Six men and one woman with mild anemia due to β-thalassemia trait and major iron overload attributable to concomitant primary hemochromatosis were treated by erythrocytapheresis to remove iron, combined with subcutaneous desferrioxamine in the four cases with greater iron load. Depletion was achieved by iron removal of 4.5-15.1 g after 9-24 months' treatment. No side effects were observed, suggesting that such a regimen is effective and safe in this particular subgroup of hemochromatotics.

Original languageEnglish
Pages (from-to)150-152
Number of pages3
JournalAmerican Journal of Gastroenterology
Volume84
Issue number2
Publication statusPublished - 1989

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Concomitant primary hematochromatosis and β-thalassemia trait: Iron depletion by erythrocytapheresis and desferrioxamine'. Together they form a unique fingerprint.

Cite this